MOSP inhibitors are a class of chemical compounds designed to specifically target and inhibit the function of MOSP, a protein that plays a role in maintaining cellular structure, signaling, and possibly vesicular transport. MOSP (Mitochondrial Outer Membrane Sorting Protein) is believed to be involved in processes related to the mitochondrial membrane and its role in sorting proteins that are directed towards specific cellular destinations, particularly in relation to the mitochondrial outer membrane. Although the exact functions of MOSP are not completely understood, it is suggested that this protein might be involved in facilitating interactions between the mitochondria and other cellular organelles, thus influencing processes such as energy production, apoptosis, and organelle dynamics. Inhibiting MOSP disrupts these processes, providing researchers with a tool to investigate how MOSP contributes to mitochondrial organization and inter-organelle communication.
In research settings, MOSP inhibitors offer valuable insights into the molecular mechanisms governing mitochondrial membrane dynamics and the broader implications of mitochondrial function in cellular processes. By inhibiting MOSP, scientists can examine how disruption of protein sorting and mitochondrial integrity affects the cell's ability to manage energy production, intracellular signaling, and apoptosis. This inhibition allows researchers to study the downstream effects on mitochondrial-dependent processes, such as oxidative phosphorylation, lipid metabolism, and cell death regulation. Additionally, MOSP inhibitors provide insights into the interactions between mitochondria and other organelles, particularly regarding membrane contacts and metabolic coordination. Through these studies, MOSP inhibitors enhance our understanding of the complex networks that maintain mitochondrial function, the regulation of intracellular transport and sorting, and the broader implications of mitochondrial activity on cellular homeostasis and vitality.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This nucleoside analog could demethylate DNA, potentially leading to the downregulation of MOSP by altering the transcriptional activity of its gene promoter. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
As a histone deacetylase inhibitor, Trichostatin A could enhance histone acetylation, resulting in a conformational change in chromatin that decreases MOSP gene expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin, by inhibiting mTOR, could reduce the translation of MOSP by interfering with the cellular growth signals that would normally increase its expression. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin could inhibit the phosphorylation of signaling molecules downstream of growth factor receptors, thereby decreasing MOSP expression linked to these pathways. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol might activate sirtuins leading to the deacetylation of histones associated with the MOSP gene, resulting in reduced transcription. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
By inhibiting PI3K, LY 294002 could decrease the expression of MOSP by attenuating the PI3K/AKT pathway, which is often associated with cellular survival and proliferation. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
This glycolytic inhibitor could lead to cellular energy depletion, which may secondarily reduce the expression of MOSP as the cell downregulates energy-intensive processes. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid could alter the differentiation status of cells and thereby decrease MOSP expression as part of a wider shift in gene expression patterns. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
This short-chain fatty acid could inhibit histone deacetylation, potentially leading to condensed chromatin structure and diminished MOSP expression. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
As a RAF inhibitor, Sorafenib might disrupt downstream ERK signaling, which could lead to a decrease in MOSP expression as part of the inhibited cell proliferation and survival signaling. | ||||||